Hepatitis Market Research Reports & Industry Analysis
Hepatitis Industry Research & Market Reports
-
Point of Care/ Rapid Diagnostics Market by Product (Glucose, HIV, Hepatitis C, Pregnancy), Platform (Microfluidics, Dipstick, Immunoassay), Purchase(OTC, Prescription), Sample(Blood, Urine), User (Pharmacy, Hospital, Homecare) - Global Forecast to 2027
... diagnostics market is projected to reach USD 75.5 Billion by 2027 from USD 45.4 Billion in 2022, at a CAGR of 10.7% during the forecast period. The growth in the point-of-care and rapid diagnostics market ... Read More
-
The World Market for Molecular Diagnostics Tests, 11th Edition
... NIPT, Other) Blood Banking Molecular Diagnostics Markets Transplantation Molecular Diagnostic Markets Regional Molecular Diagnostics Markets (North America, Europe, Asia, Global) This report is published as the industry experienced accelerated installed bases and new product introductions. ... Read More
-
Preventive Vaccines Market, By Vaccine Type (Live/Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, and Other Vaccine Types), By Disease Type (Pneumococcal, Poliovirus, Hepatitis, Influenza, Measles, Mumps, and Rubella (MMR), and Other Disease Types), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Preventive vaccines protect people from serious and life-threatening infectious diseases. These vaccines help ... Read More
-
Autoimmune Hepatitis - Pipeline Insights, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Travel Vaccine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027Segmented By Composition (Mono Vaccines v/s Combination Vaccines), By Disease Indication (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others), By Travel Type (Domestic v/s International) and By Region
... Varicella, Japanese Encephalitis, Others), By Travel Type (Domestic v/s International) and By Region The global travel vaccine market is anticipated to grow at a steady rate in the forecast period, 2023-2027. The market growth can ... Read More
-
Chronic Hepatitis B Virus Infection - Pipeline Insight, 2022
... Infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2022
... Delta Virus (HDV) Infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It ... Read More
-
Hepatitis C Virus Envelope Protein E2 Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Out of which approximately 5 molecules are developed by companies and remaining by the universities/institutes. The latest report Hepatitis C Virus Envelope Protein E2 - Drugs In Development, 2022, outlays comprehensive information on the Hepatitis ... Read More
-
Hepatitis Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... health care services has had a substantial impact on the delivery of care and outcomes for patients with chronic diseases. Therefore, there has been a decline in the treatment, diagnosis, and follow-up of patients with ... Read More
-
PEGylated Proteins Market Size, Share & Trends Analysis Report By Protein Type (CSF, Interferons), By Application (Cancer, Hepatitis), By Product & Services (Consumables, Services), By End-user, And Segment Forecasts, 2022 - 2030
... Growth & Trends The global PEGylated proteins market size is expected to reach USD 3.06 billion by 2030, registering a CAGR of 11.71% over the forecast period, according to a new report by Grand View ... Read More
-
Vaccine Adjuvants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... exports due to facility closures during the COVID-19 pandemic had a short-term adverse impact on the market's growth in the pandemic's preliminary phase due to supply chain disruptions and the unavailability of human resources. However, ... Read More
-
Global Hepatitis A Vaccine Market - 2022-2029
... 3.5% over the forecast period 2022 to 2029. Hepatitis A vaccine is a vaccine that prevents hepatitis A. The disease is a liver disorder caused by the hepatitis A virus leading from mild to severe ... Read More
-
Global Vaccines Market - 2022-2029
... the forecast period (2022-2029). A vaccine is a type of medicine that trains the body’s immune system to fight diseases it has not come into contact with before. Vaccines are developed to prevent disease; when ... Read More
-
Global Infectious Disease In Vitro Diagnostics Market Size study & Forecast, by Product (Instruments, Reagents, Software), by Application (Respiratory Virus, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, HIV, Hepatitis, COVID-19, Others), by Technology (Immunoassay, Molecular Diagnostics, Others, Microbiology) and Regional Analysis, 2022-2029
... Diagnostics, Others, Microbiology) and Regional Analysis, 2022-2029 Global Infectious Disease In Vitro Diagnostics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape
... be more than 36.000 diagnosed incidence cases of Autoimmune Hepatitis across 16 pharmaceutical markets. No FDA-approved marketed drugs are available for Autoimmune Hepatitis. However, there are several treatments used off-label to manage Autoimmune Hepatitis. Among ... Read More
-
North America Immunodiagnostic Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays (Vitamin D Assay, HIV Detection, HIV Ag/Ab Combo Assay, and Others), Radioimmunoassays, and Others], Clinical Indication [Infectious Diseases (COVID-19, Lyme, Zika, Infection Management, TORCH, Tuberculosis, Treponema, Measles & Mumps, EBV, and VZV), Hepatitis+HIV, Gastrointestinal, Metabolics[PL1] , Endocrinology (Hypertension, GROWTH, Diabetes, Thyroid, and Reproductive Endocrinology), and Others], and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others) [PL2]
... Clinical Indication [Infectious Diseases (COVID-19, Lyme, Zika, Infection Management, TORCH, Tuberculosis, Treponema, Measles & Mumps, EBV, and VZV), Hepatitis+HIV, Gastrointestinal, Metabolics[PL1] , Endocrinology (Hypertension, GROWTH, Diabetes, Thyroid, and Reproductive Endocrinology), and Others], and End User ... Read More
-
Hepatitis E Diagnostic Tests Market By Test Type (ELISA HEV IgM Test, ELISA HEV IgG Test, RT-PCR Test), By End User (Hospitals, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... E diagnostic tests market was valued at $61.69 million in 2021, and is projected to reach $93.5 million by 2031, registering a CAGR of 4.2% from 2022 to 2031. Hepatitis E is a type of ... Read More
-
Global Liver Disease Market, Global Forecast 2023-2027, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis
... organ that plays significant functions like storing vitamins and nutrients, maintaining an adequate balance of chemicals in the body, and removing harmful substances from the blood. Non-alcoholic Fatty Liver Disease, Cancer, hepatitis, autoimmune diseases, and ... Read More
-
Hepatitis B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Hepatitis B (Infectious Disease) pipeline landscape. Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus. Hepatitis B virus can cause an acute illness with symptoms ... Read More
-
Global Hepatitis E Diagnostic Tests Market - 2022-2029
... a CAGR of 4.5 % during the forecast period (2022-2029). The hepatitis E virus causes the enteric liver disease known as hepatitis E. (HEV). It belongs to the group of five known human hepatitis viruses ... Read More
-
Point of Care (PoC) Molecular Diagnostics Market Analysis and Forecast to 2031: By Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), By Application (Infectious Disease, {Flu, Respiratory Syncytial Virus (RSV), Tuberculosis (TB), HIV, Gonorrhoea, Chlamydia, Hepatitis C, Hepatitis B}, Oncology, Hematology), By End-use (Hospitals, Clinics) and Region
... Hepatitis C, Hepatitis B}, Oncology, Hematology), By End-use (Hospitals, Clinics) and Region The global pulse oximeter market was valued at USD 2.2 billion in 2021 and it is anticipated to grow up to USD 2.6 ... Read More
-
The 2022 World Market for Vaccines
... some of the deadliest dis eases that pose significant risk to human life. Sales increased from $127.6 billion in 2021 to $202.6 billion in 2022. Compare this to just $25 billion in 2010. Since the ... Read More
-
Hepatitis C Testing Market By Technique (Immunoassay, PCR, Other techniques), By Test (Antibody test, Genotype tests, Viral load test), By End User (Hospital and diagnostic laboratory, Blood banks, Other end users): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Industry Forecast, 2021-2031 The global hepatitis C testing market was valued at $1,329.0 million in 2021, and is projected to reach $2,248.2 million by 2031, registering a CAGR of 5.3% from 2022 to 2031. Hepatitis ... Read More
-
Hepatitis A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Hepatitis A (Infectious Disease) pipeline landscape. Hepatitis A is inflammation of the liver caused by hepatitis A virus. Symptoms include fatigue, nausea and vomiting, inflammation of the liver, loss of ... Read More
-
Global Specialty Generics Market Size study, by Type (Injectables, Oral Drugs, Others), By Application (Oncology, Inflammatory Conditions, Hepatitis C, Multiple Sclerosis, Others) by End-use (, Retail, Hospital, Others) and Regional Forecasts 2022-2028
... Market is valued approximately USD 67.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.20% over the forecast period 2022-2028. When a specialty drug's patent expires, it's ... Read More
Research Assistance
